• 1
    Rossi AC, Mullin P. The etiology of maternal mortality in developed countries: a systematic review of the literature. Arch Gynecol Obstet 2012;285:1499503.
  • 2
    Callaghan WM, MacKay AP, Berg CJ. Identification of severe maternal morbidity during delivery hospitalizations, United States, 1991–2003. Am J Obstet Gynecol 2008;199:133.e18.
  • 3
    Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC, 2010. MMWR Recomm Rep 2010;59: No. RR-10.
  • 4
    Hamilton BE, Martin JA, Ventura SJ. Births: preliminary data for 2011. Nat Vital Stat Rep 2012;61:120.
  • 5
    Centers for Disease Control and Prevention 2012. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus. 2011.
  • 6
    Culver DH, Horan TS, Gaynes RP, Martone WJ, Jarvis WR, Emori G, et al. Surgical wound infection rates by wound class, operative procedure, and patient risk index. National Nosocomial Infections Surveillance System. Am J Med 1991;91:152S7S.
  • 7
    Baaqeel H, Baaqeel R. Timing of administration of prophylactic antibiotics for caesarean section: a systematic review and meta-analysis. BJOG 2013;120:6619.
  • 8
    Smaill FM, Gyte GML. Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section. Cochrane Database Syst Rev 2010;1: Art. No.:CD007482.
  • 9
    Antimicrobial prophylaxis for cesarean delivery: timing of administration. Committee opinion No. 465. American College of Obstetricians and Gynecologists. Obstet Gynecol 2010;116:7912.
  • 10
    Puopolo KM, Eichenwald EC. No change in the incidence of ampicillin-resistant, neonatal, early-onset sepsis over 18 years. Pediatrics 2010;125:e-10318.
  • 11
    Lozupone CA, Strombaugh I, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature 2012;489:22030.
  • 12
    Southey R. The Story of the Three Bears, 2nd edn. London: Pall-Mall, 1839.